
Allan Gibofsky, MD, JD
Advertisement
Articles by Allan Gibofsky, MD, JD
Advertisement
Latest Updated Articles
Biosimilars for Immune-Mediated Inflammatory Diseases – A Managed Care PerspectivePublished: November 1st 2022 | Updated:
Overview of Biosimilars for Immune-Mediated Inflammatory Diseases: Summary of Current EvidencePublished: November 1st 2022 | Updated:
Provider and Patient Knowledge Gaps on Biosimilars: Insights From SurveysPublished: November 1st 2022 | Updated:
Overview of Epidemiology, Pathophysiology, and Diagnosis of Rheumatoid ArthritisPublished: December 24th 2012 | Updated:
Comparative Effectiveness of Current Treatments for Rheumatoid ArthritisPublished: December 24th 2012 | Updated:
Epidemiology, Pathophysiology, and Diagnosis of Rheumatoid Arthritis: A SynopsisPublished: May 31st 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Advances in MASLD and MASH Care Highlight Progress and Persistent Gaps
2
Howard A. “Skip” Burris, III, MD: An Oncology Pioneer Reflects on Patients, Progress, and Purpose
3
Employer Premiums and Deductibles Consume Significant Portion of Income in 19 States
4
New Bill Makes CMS Enforcer in PBM, Pharmacy Relationship: A Q&A With Jesse Dresser, Esq
5